Evidence map›Paper›PMID 30918906›Full record

ArticleJournal of arthropod-borne diseases2018

Evaluation of Pyrethroid Susceptibility in

Onur Guntay, Mehmet Salih Yikilmaz, Huseyin Ozaydin, Savas Izzetoglu, Asli Suner

Open access · diamondAbstract read
In one paragraph

Article in Journal of arthropod-borne diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Onur GuntaySection of Molecular Biology, Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.
Mehmet Salih YikilmazSection of Molecular Biology, Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.
Huseyin OzaydinSection of Molecular Biology, Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.
Savas IzzetogluSection of Molecular Biology, Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.
Asli SunerDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Ege University, Izmir, Turkey.
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMosquitoes, being a nuisance species, are considered as one of the most important species in public health control programs due to their role as a vector in mosquito-borne diseases observed in humans and animals. We evaluated the susceptibility status of

methodsMosquito larvae, collected from three different locations in northern İzmir, were reared in the laboratory. Adult susceptibility bioassays were performed using the WHO insecticide-impregnated papers including deltamethrin 0.05%, permethrin 0.75%, α-cypermethrin 0.05% and cyfluthrin 0.15%. In addition, adult bioassays were performed after the pre-exposure to piperonyl butoxide (PBO) to determine the contribution of P450 detoxification enzymes to the phenotypic resistance.

resultsIn all of the three populations, high levels of resistance were observed (mortalities<63%) to all of the four pyrethroids. Different pyrethroids but with the same mode of action can exhibit significantly different phenotypic resistance in a single population. PBO bioassays also showed that P450 detoxification enzymes can have diverse effects on different pyrethroids.

conclusionUsing just one chemical in a class of insecticide can be misleading for resistance studies.

Indexed as

BioassayCulex pipiensInsecticide resistancePiperonyl butoxidePyrethroids

Identifiers

PMID30918906
PMCPMC6423456
OpenAlexW2903744074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.